Olga A. Shatskaya

Olga A. Shatskaya

Auto-generated profile, based on publicly available information

Olga A. Shatskaya

Endocrinology Research Centre

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
22 November 2022 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
OVOksana I. Vengrzhinovskaya
Oksana I. Vengrzhinovskaya
IBIrina Z. Bondarenko
Irina Z. Bondarenko
OSOlga A. Shatskaya
Olga A. Shatskaya
LNLarisa V. Nikankina
Larisa V. Nikankina
VKViktor Y. Kalashnikov
Viktor Y. Kalashnikov
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Early screening of complications of diabetes mellitus (DM) is one of the priorities for public health. Most patients with type 1 diabetes mellitus (T1DM) are patients of working age. New strategies for the primary prevention of cardiovascular disease (CVD) are needed to prevent their early disability. Aim. To assess the predictive value of adipokines in relation to a personalized approach to the need for an in-depth examination of young patients with T1DM. Materials and methods. The study included 98 patients without CVD: 70 patients with T1DM (mean age 26.48.1 years) and 28 patients without DM (mean age 279 years). All patients underwent a general clinical examination, the levels of adipokines were determined, ergospirometry, echocardiography, and bioimpedancemetry were performed. Results. Changes in the cardiorespiratory system in patients with T1DM were revealed, in comparison with persons without T1DM: anaerobic threshold was reached faster (p=0.001), maximum oxygen consumption was lower (p=0.048), metabolic equivalent was reduced (p=0.0001). Signs of myocardial remodeling were found in the T1DM group: there was an increase in the relative wall thickness (p=0.001), the posterior wall of the left ventricle (p=0.001), myocardial mass index (p=0.049), in comparison with persons without T1DM. Changes in the adipokines system were revealed: higher levels of resistin (p=0.002) and visfatin (p=0.001), lower level of adiponectin (p=0.040) in T1DM. A positive correlation was found between posterior wall of the left ventricle and visfatin (p=0.014) and a negative relationship between adiponectin and relative wall thickness (p=0.018) in T1DM. Conclusion. In T1DM, even at a young age, there are multifactorial changes in the heart, which can be detected even at the preclinical stage. The data obtained can be used to identify groups of patients at high risk of developing dangerous CVD in T1DM, which can form the basis for determining the timing of the start of preventive therapy.

31 October 2024 in Meditsinskiy sovet = Medical Council
Verified
Journal Article
Open access
PDF file
OSO. A. Shatskaya
O. A. Shatskaya
IBI. Z. Bondarenko
I. Z. Bondarenko
SKSvetlana Kushnarenko
Svetlana Kushnarenko
Diabetes mellitus is a group of metabolic (chemical processes) diseases characterized by chronic hyperglycemia. Globally, the number of patients with diabetes mellitus follows an upward trend with an annual increase. As the disease progresses, the frequency of the micro and macrovascular complications of diabetes gradually increases. In recent years, much attention has been paid to the effect of diabetes mellitus on the skeletal muscle status. Structural and functional abnormalities, and metabolic disorders in skeletal muscles that develop with ageing are also specifically attributed to patients with diabetes, but they manifest themselves at an earlier age. Chronic hyperglycemia can accelerate the ageing process and play a crucial role in the development of diabetic myopathy, which is characterized by decreased muscle mass, skeletal muscle weakness and atrophy, pain, impaired sensation and even quadriplegia in severe cases. A reduction in the rate of muscle protein synthesis and a rise in the rate of its degradation is a pathophysiological sign of diabetic muscle atrophy. Research into the molecular mechanisms of diabetic myopathy will aid the development of effective methods of prevention and treatment, however, the achievement and maintenance of glycaemic targets plays a critical role in ensuring health of skeletal muscles, which will make it possible to achieve the reduction in disability and improve the patients’ quality of life. Advanced glucometer models fitted with a range of additional functions allow for structured self-monitoring of blood glucose (SMBG), analysis of the obtained data and timely correction of therapy, active involvement of patients in the process of diabetes management, which will significantly increase the effectiveness of disease management and reduce the risk of complications in patients with diabetes.

23 November 2023 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
OVO I Vengrzhinovskaya
O I Vengrzhinovskaya
IBI Z Bondarenko
I Z Bondarenko
OSO A Shatskaya
O A Shatskaya
NTN V Tarbaeva
N V Tarbaeva
AKA Y Korneluk
A Y Korneluk
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Cardiovascular disease (CVD) in type 1 diabetes mellitus (T1DM) is preceded by asymptomatic changes in the geometry of the heart. The only symptoms of the beginning of cardiac remodeling and concomitant predictors of an unfavorable cardiovascular prognosis are: thickening of epicardial fat (EAT), secreting a number of adipokines, and cardiospecific miRNAs. To improve the effectiveness of prevention of CVD in young patients with DM1, a search was made for structural-functional and epigenetic markers. Aim. To assess the state of the cardiovascular system according to MRI-heart with T1 mapping in T1DM without CVD. To reveal the relationship of epigenetic markers (circulating miR-126-5p, miR-21-5p) and adipokines with cardiovascular system in T1DM. Suggested personalized approach to patients with T1DM with initial manifestations of joint remodeling and/or exclusion of cardiospecific microRNA. Materials and methods. The study included 40 patients: 30 with T1DM (age 26.2±7.4 years), 10 without T1DM (26.4±8.2). The patients underwent a general clinical examination, bioimpedancemetry, electrocardiography, MRI of the heart with T1 mapping, determination of adiponectin, resistin, visfatin, NT-proBNP, miR-126-5p, miR-21-5p. Results. Patients with T1DM had lower levels of cardioprotective miR-126-5p (p=0.046). According to MRI of the heart in T1DM, signs of vascular remodeling were revealed – thickening of the interventricular septum (p=0.001), posterior wall (p=0.012) and relative size of the walls (p=0.048) of the left ventricle, an increase in EAT density (p=0.001). Diffuse vascular fibrosis was found in 16% of patients from the T1DM group. Also, in T1DM, the expression of visfatin is increased (p=0.036) and adiponectin is reduced (p=0.043). Conclusion. Structural and functional changes in the cardiovascular system (including thickening of the EAT), shifts in miR-126-5p expression and adipokines profile are observed already at a young age in patients with T1DM. In T1DM, diffuse vascular fibrosis is detected in 16% of patients. The data obtained were used to identify the group increased risk of developing CVD in T1DM and served as the basis for determining the timing of the start of preventive therapy.

18 January 2025 in Diabetes mellitus
Verified
Journal Article
Open access
PDF file
IKI. A. Khamnagadaev
I. A. Khamnagadaev
AZA. S. Zotov
A. S. Zotov
OSO. O. Shelest
O. O. Shelest
IBI. A. Bulavina
I. A. Bulavina
AGA. A. Glupak
A. A. Glupak
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
BACKGROUND: Treatment of patients with diabetes mellitus (DM) and a long-term persistent form of atrial fibrillation (AF) is an unsolved problem of the healthcare system due to a high risk of disability and mortality. Considering low effectiveness of drug treatment for AF, surgical technologies have been introduced into clinical practice in most countries, but their effectiveness has not been validated for patients with DM. According to various researches isolated interventional treatment of patients with AF and DM is associated with a high rate of recurrence compared to patients without disorders of carbohydrate metabolism. The feasibility of using other surgical approaches (the isolated thoracoscopic procedure or the isolated thoracoscopic procedure in combination with intracardiac intervention) for the treatment of AF for patients with DM has not been determined yet.AIM: To evaluate the effectiveness and safety of a staged surgical approach to release patients with DM from AF.MATERIALS AND METHODS: The study included 19 patients aged 53–73 with DM and long persistent AF. Among them there were 4 (21,4%) women and 15 (78,9%) men. To maintain sinus rhythm all patients were undergone with thoracoscopic epicardial ablation. In three mounts, later the invasive electrophysiological studies and radiofrequency ablation were carried out due to reconnection of left atrium (LA).RESULTS: At the end of the blinded period sinus rhythm was maintained for 17 (89,5%) patients during the observation period. Two patients (10.5%) had AF recurrence. In both cases, the second stage of treatment wasperformed (electrophysiology study and endocardial ablation). Amid normal sinus rhythm after thoracoscopic epicardial ablation the volume of the LA (p=0,013) and the N-terminal prohormone of brain natriuretic peptide (NT-proBNP) (p=0,014) significant decreased. No adverse events were recorded in the perioperative or long-term periods.CONCLUSION: Аccording to our pilot study, the staged approach to surgical maintenance of sinus rhythm for patients with diabetes and persistent form of atrial fibrillation can be an optimal strategy. The endocardial stage could be performed for this category of patients in case of recurrence of tachysystolic cardiac arrhythmias.

27 December 2024 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
PDF file
OVOksana I. Vengrzhinovskaya
Oksana I. Vengrzhinovskaya
IBIrina Z. Bondarenko
Irina Z. Bondarenko
OSOlga A. Shatskaia
Olga A. Shatskaia
NTNatalia V. Tarbaeva
Natalia V. Tarbaeva
AKAnastasya Iu. Korneluk
Anastasya Iu. Korneluk
КЮКорнелюк Анастасия Ю.
Корнелюк Анастасия Ю.
Background. Type 1 diabetes mellitus (DM 1) disrupts all types of metabolism, especially carbohydrate and lipid ones, leading to many complications. The most serious DM complication is damage to the cardiovascular system (CVS). Prolonged preclinical changes precede the development of pathological processes in the CVS. One of the earliest manifestations of cardiovascular system dysfunction is myocardial remodeling. In patients with DM 1, myocardial remodeling is diagnosed using echocardiography. However, the examination algorithm does not include echocardiography for young patients with DM 1 without evident cardiovascular diseases (CVD). The state of the heart's extracellular matrix and the presence of fibrotic changes in it are actively studied as a marker of changes in the CVS at the preclinical stage. Assessment of the presence of fibrosis foci is available during echocardiography; however, it is generally relevant for patients with DM 1 with pre-existing CVD. The initial formation of diffuse fibrosis (DF) of the myocardium in patients with DM without diagnosed CVD can be verified by magnetic resonance imaging (MRI) of the heart. Given that DF increases the risk of life-threatening arrhythmias and significantly increases the risk of sudden cardiac death in young patients with DM 1, it is necessary to revise the strategy of primary prevention of CVD for patients in this population. Aim. To assess the CVS structural and functional state in young patients with DM 1 without CVD according to echocardiography and MRI of the heart using T1 mapping. To determine the presence and instrumental imaging options of fibrous tissue in the myocardium without laboratory markers of its formation in young DM 1 patients without CVD. Materials and methods. The study included 110 participants without CVD and obesity: 80 patients with DM 1 (mean age 26 years) and 30 patients in the comparison group without DM (mean age 27 years). All participants underwent a general clinical examination, bioelectrical impedance analysis, electrocardiography, echocardiography, and cardiac MRI with T1 mapping. Conclusion. DF of the myocardium was detected using heart MRI in 8.7% of young patients with DM 1. In healthy peers, these changes in the myocardium were not detected. The group of patients with DM 1 and DF of the myocardium had a longer duration of the disease (8 years vs 5 years) and more severe initial structural changes in the myocardium (according to echocardiography) compared to patients with DM 1 without myocardial fibrosis. In the presence of initial signs of myocardial remodeling in patients with DM 1, it is advisable to conduct a heart MRI to exclude the DF formation.

27 August 2026 in Terapevticheskii arkhiv
Verified
Journal Article
Open access
ALAlina A. Lobkova
Alina A. Lobkova
IBIrina Z. Bondarenko
Irina Z. Bondarenko
OSOlga A. Shatskaya
Olga A. Shatskaya
LNLarisa V. Nikankina
Larisa V. Nikankina
ASArina I. Sleptsova
Arina I. Sleptsova
NMNatalia G. Mokrysheva
Natalia G. Mokrysheva
Aim. To assess body composition and nutritional status in young patients with type 1 diabetes mellitus (T1D) and to identify their associations with biochemical markers: interleukin 6 (IL 6), superoxide dismutase (SOD), and fibroblast growth factor 21 (FGF 21). Materials and methods. The study included 50 patients with T1D and 30 healthy volunteers. All participants underwent bioelectrical impedance analysis (InBody 770), calculation of the Prognostic Nutritional Index (PNI), and measurement of serum IL 6, FGF 21, and SOD levels using a sandwich ELISA. Results. In young patients with T1D, appendicular lean mass index (ALMI) and fat free mass index (FFMI) were within reference ranges, and sarcopenia was detected in 1 case (2%). At the same time, the T1D group showed early adverse body composition and nutritional changes, including increased FFMI, a trend toward higher visceral fat area, and reduced PNI. Phase angle was associated with ALMI and FFMI in both groups and, in the T1D group, was inversely correlated with disease duration and visceral fat area. In patients with T1D, there were trends toward higher IL 6 and lower FGF 21 and SOD levels, as well as associations of these biochemical markers with body composition and nutritional parameters. Conclusion. In this study, young patients with T1D demonstrated early alterations in body composition and nutritional status without loss of muscle mass. Phase angle may be considered a potential marker of unfavorable body composition and nutritional changes in this population. The biochemical markers (IL 6, FGF 21, and SOD) reflect the pathophysiological mechanisms that form the substrate for the development and progression of metabolically associated complications in T1D.